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Abstract
 
Immunoglobulin A (IgA) provides protection against pathogens at mucosal surfaces. Chemotactic
responses have been hypothesized to target IgA plasma cells involved in mucosal immune
responses. We show here that thymus-expressed chemokine (TECK, CCL25) is a potent
and selective chemoattractant for IgA antibody-secreting cells (ASC), efficiently recruiting
IgA-producing cells from spleen, Peyer’s patches, and mesenteric lymph node. Cells secreting
IgA antibody in response to rotavirus, an intestinal pathogen, also respond well. In con-
 
trast, IgG– and IgM–ASC respond poorly. Epithelial cells in the small intestines, a principal
site of IgA–ASC localization and IgA production in the body, highly and selectively express
TECK. The migration of IgA–ASC to the intestinal epithelial cell chemokine TECK may
help target IgA-producing cells to the gut wall, thus helping define and segregate the intestinal
immune response.
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Introduction
 
Humoral immunity in mucosal tissues, especially the gas-
trointestinal mucosa, is characterized by local production
and secretion of IgA, and the intestinal lamina propria
 
(LP)
 
*
 
 harbors many IgA-producing plasma cells initially
recruited from circulating antibody-secreting cells (ASC;
for a review, see references 1 and 2). In contrast, IgG–
ASC predominate in systemic (nonmucosal) chronic in-
flammatory sites, for example in arthritis or soft tissue in-
flammation, and IgM–ASC, which produce the initial
wave of low affinity antibodies during the primary im-
mune response, are prominent within lymphoid organs
(3). Early studies demonstrating mucosal lymphoid-derived
ASC migration to factors in mouse colostrum led to the
hypothesis that ASC might be targeted to mucosal surfaces
by epithelium-derived chemoattractants (4). Since chemo-
attractant cytokines (chemokines) play major roles in the
in vivo homing of other leukocyte subsets to lymphoid
and extralymphoid tissues (5, 6), we set out to assess the
chemokine responsiveness of cells secreting antibodies of
different isotypes.
 
Materials and Methods
 
Chemotaxis.
 
Lymphocytes from mouse spleen, Peyer’s patch,
mesenteric lymph node, and bone marrow (BM) from male and
female C57Bl6/J mice were isolated and migration assays were
performed as described previously (7). Briefly, 2 
 
 
 
 10
 
6
 
 lympho-
cytes were placed in 5-
 
 
 
 Transwell inserts (Costar) in wells with
medium alone (basal) or medium containing chemokines at con-
centrations shown previously to be optimal for chemotaxis of
various responding BM and peripheral leukocyte populations (7)
(100 nM mKC, 100 nM monokine induced by IFN-
 
 
 
 (MIG), 50
nM stromal cell–derived factor (SDF-1
 
 
 
), 500 nM mBLC, 100
nM mMIP-1
 
 
 
, 1 nM mJE, 100 nM mEotaxin, 100 nM hTARC,
100 nM mRANTES, 100 nM hMIP-3
 
 
 
, 100 nM hELC, 100
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Abbreviations used in this paper:
 
 ASC, antibody-secreting cells; BM,
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induced by IFN-
 
 
 
; RV, rotavirus; SDF, stromal cell–derived factor;
TECK, thymus-expressed chemokine. 
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nM hI-309, or 300 nM thymus-expressed chemokine [TECK]).
Chemokines were obtained from Peprotech, Inc. or R&D Sys-
tems. None of the populations tested responded to eotaxin or
I-309. After 2 h, inserts were removed and the responding popu-
lation in the bottom wells was quantified as described below. For
evaluation of migrated ASC, multiple replicate chemotaxis wells
(generally 4–5 per condition in each experiment) were combined
for ELISPOT analyses.
 
Flow Cytometric Analysis.
 
Follicular B lymphocytes were enu-
merated using a bead counting method as described previously
(7). The mAbs used during this analysis were RA3–6B2 (APC-
conjugated rat anti–mouse CD45R/B220; BD PharMingen);
145–2C11 (biotin-conjugated Armenian hamster anti–mouse
CD3
 
 
 
; BD PharMingen); AF6–78 (PE-conjugated rat anti–
mouse IgMb; BD PharMingen); B3B4 (PE-conjugated rat anti–
mouse CD23; BD PharMingen); 11–26c.2a (FITC-conjugated
rat anti–mouse IgD; BD PharMingen); and 7G6 (FITC-conju-
gated rat anti–mouse CD21; BD PharMingen).
 
ELISPOT Assay.
 
IgM–ASC, IgG–ASC, and IgA–ASC were
identified in conventional ELISPOT assays (8, 9). Nitrocellulose
96-well plates (Multiscreen 96-well filtration plate; Millipore)
were coated with goat anti–mouse IgM-, IgG-, and IgA-specific
polyclonal antibodies (all from Kirkegaard and Perry) to capture
the respective secreted Igs from the ASC during overnight cul-
ture. ASC were removed and the captured Ig was detected with
HRP-conjugated goat anti–mouse IgM, IgG, or IgA, respectively
(Kirkegaard and Perry), and visualized by development with
3-amino-9-ethylcarbazole for 15–20 min to yield a reddish spot
where an ASC had been. The number of ASC per well was de-
termined by counting under a dissecting microscope, and the effi-
ciency of migration calculated by comparing the number of spots
present in the input population with the number of spots present
in the migrated population.
The above protocol was modified to detect rotavirus (RV)-
specific IgA–ASC. After chemotaxis of an ASC-enriched popula-
tion to chemokines, the responding cells were harvested and
plated overnight onto nitrocellulose plates precoated with virus-
like particles made from baculovirus heterologously expressing
bovine RV VP6 and VP2 (8, 9). J. Cohen (Virologie Moleculaire
et Cellullaire, Cedex, France) provided the virus-like particles.
Plates were washed, incubated with HRP-conjugated goat anti–
mouse IgA or IgG polyclonal antibodies, and developed as de-
scribed above.
 
RT-PCR Analysis of CC Chemokine Receptor 9 mRNA in Splenic
ASC Subsets.
 
3,000–4,000 splenic IgA and IgG ASC were iso-
lated based on their unique cell surface phenotype (B220
 
lo/
 
 
 
,
IgG
 
 
 
 or IgA
 
 
 
, and negative for myeloid and T cell antigens), as
described previously (10).
Splenocytes were initially enriched for ASC by streptavidin-
conjugated magnetic bead (Dynal) depletion of cells stained with
biotinylated rat anti–mouse Thy-1.2 (Clone 53–2.1; BD Phar-
Mingen), IgD (Clone 11–26; Southern Biotechnology, Inc.), and
CD11b/MAC-1 (Clone M1/70; American Type Culure Collec-
tion). ASC enriched splenocytes were then stained for FACS
 
®
 
sorting with biotinylated rat anti–mouse Thy-1.2, IgD, and
CD11b/MAC-1, and CD45R/B220-PE (BD PharMingen), in
combination with either rat anti– mouse IgA–FITC (Clone C10–3;
BD PharMingen), IgG1–FITC
 
 
 
IgG2a/2b-FITC
 
 
 
IgG3–FITC
(Clones A85–1, R2–40, and R40–82, respectively; BD PharMin-
gen), or rat IgG2a–FITC as a negative control (Clone R-35–95;
BD PharMingen). In one experiment, anti–mouse CD11c was
added to this depleting antibody cocktail to exclude possible den-
dritic cell contamination. Biotinylated antibodies were visualized
 
with streptavidin-Cy-Chrome (BD PharMingen) and FITC-
staining was amplified using the Alexa Fluor 488 Signal Amplifi-
cation kit for Fluorescein-conjugated probes (Molecular Probes).
The sort gate for ASC was set for B220
 
lo/
 
 
 
, Thy-1.2
 
 
 
, IgD
 
 
 
,
CD11b/Mac-1
 
  
 
  
 
CD11c
 
 
 
 large lymphocytes and the FITC
amplified background was determined using rat IgG2a-FITC
stained cells. Sort gates for IgA
 
 
 
 and IgG
 
 
 
 ASC were identical.
Sorted cells (generally 3,500–5,000 IgA
 
 
 
 or IgG
 
 
 
 ASC pheno-
type cells) were lysed in guanidinium buffer and the total RNA
isolated by phenol/chloroform extraction. The RNA was reverse
transcribed using the Advantage RT-for-PCR kit (CLON-
TECH). PCR and Southern Blot analysis were performed as de-
scribed previously (11). The intron-spanning PCR primers for
mouse CC chemokine receptor (CCR)9 were 5
 
 
 
-CCTC-
TCCTTACAGACCCAGAC-3
 
 
 
 and 5
 
 
 
-GTCATGGTCTTC-
ACTCTTGTGC-3
 
 
 
. As a loading control, PCR products for
mouse GAPDH were created using intron-spanning PCR prim-
ers that were 5
 
 
 
-CCATGTTTGTGATGGGTGTG-3
 
 
 
 and 5
 
 
 
-
CCTTCTTGATGTCATCATAC-3
 
 
 
.
 
Isolation of and Chemotaxis by LP Lymphocytes.
 
LP lympho-
cytes (LPLs) were isolated from normal murine small intestine as
described in reference 12. Briefly, 4–5 small intestines were
cleared of Peyer’s patches, cut open longitudinally, cut into short
5-mm segments, and washed at room temperature with vigorous
shaking four times in divalent cation-free HBSS supplemented
with 5 mM EDTA, 25 mM Hepes, and 2.5% antibiotic-antimy-
cotic (Sigma-Aldrich) to remove epithelial cells and intraepithe-
lial lymphocytes until no more shedding occurred. Intestines
were then washed twice in RPMI 1640 with 10% FCS/15 mM
Hepes/2.5% antibiotic-antimycotic. LPLs were isolated by shak-
ing the intestinal pieces in the RPMI 1640 supplemented with
20% BCS/25 mM Hepes/antibiotic-antimycotic and 300 U/ml
collagenase Type VIII (Sigma-Aldrich) for three 40-min sessions.
At the end of each 40-min incubation, released cells were imme-
diately washed in RPMI 1640/10% BCS containing penicillin-
streptomycin to remove and neutralize the collagenase. LPLs
were allowed to recover in RPMI 1640/10% FCS containing
penicillin-streptomycin in a CO
 
2
 
 incubator for 2 h before any
analysis. Migration of LPLs was performed in RPMI 1640 sup-
plemented with 0.5% BSA instead of serum to decrease back-
ground migration of lymphocytes. Responding cells were stained
as outlined in the figure legend.
 
ASC Enrichment for Chemotaxis Assays. 
 
Mesenteric lymph
node cells were harvested 10 d after conventional oral inoculation
of mice with RV (8, 9). The cell preparation was enriched for
ASC (B220
 
lo/neg
 
, IgD
 
 
 
, nonT cells) by precoating goat anti–rat
IgG-conjugated Dynalbeads (Dynal) with rat anti–mouse CD4,
CD8, and IgD antibodies (all FITC conjugated) individually. The
individually coated beads were combined, washed, and incubated
with the cell preparation for 45 min at 4
 
 
 
C. CD4
 
 
 
, CD8
 
 
 
, and
IgD
 
 
 
 cells were removed with a magnet and the unbound ASC-
enriched population was transferred and placed in culture for 1 h
at 37
 
 
 
C to recover before assay. 
 
Results and Discussion
 
 We initially analyzed ASC from spleen, a central filtering
and collecting organ for circulating immune cells that com-
prises plasma cells of each isotype. Spleen cells were iso-
lated, placed in an upper Transwell chamber, and allowed
to migrate to individual chemokines placed in the bottom
well. ASC in the starting population and in the bottom 
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well after migration to specific chemokines or control me-
dia were enumerated by conventional ELISPOT assays,
and the percent of ASC migrated was determined. The mi-
gration of naive follicular B cells, a population that circu-
lates through secondary lymphoid tissues but not the gut
wall, is presented for comparison.
Fig. 1 A shows that IgM-ASC failed to respond well to
any chemokine tested, although they migrated above back-
ground to SDF-1
 
 
 
, (CXCL12), a widely expressed che-
mokine ligand for CXC chemokine receptor (CXCR)4
that is active on many lymphocyte subsets. IgG–ASC (Fig.
1 A) displayed a detectable but weak SDF-1
 
 
 
 response, as
well, but also migrated significantly to MIG (CXCL9), a
ligand for CXCR3. CXCR3 and its ligands have been im-
plicated in inflammatory T cell migration (13); thus, migra-
tion to MIG may help IgG–ASC enter diverse tissue sites
of inflammation.
The most dramatic chemotactic responses, however,
were displayed by IgA–ASC (Fig. 1 A, right panel). These
IgA-producing cells respond well to SDF-1 
 
 
 
 (a chemo-
Figure 1. TECK selectively attracts IgA ASC. (A) Mouse splenocytes were
migrated to optimal chemokine concentrations as described in Materials and
Methods. Follicular B lymphocytes were identified by flow cytometry as B220 /
CD3  /IgMlo/IgDhi or B220 /CD3  /CD21int/CD23int cells. IgM–ASC, IgG–
ASC, and IgA–ASC were identified in conventional ELISPOT assays (reference 9).
The average migration from 7 to 9 experiments is presented with SE. The fre-
quency of IgM–, IgG–, and IgA–ASC in the spleen was 110   30, 50   10, and
60   20 per 106 total cells plated, respectively. (B) ELISPOT assays illustrating
IgA-ASC (spots) in the starting spleen cell population, and among cells migrated to
TECK. In contrast, no IgA–ASC was detected in cells that migrated spontaneously
with only medium in the attractant well (basal migration). (C) Sorted splenic IgA 
(but not IgG ) ASC express mRNA for CCR9. CCR9 message was abundant in
IgA–ASC in 3/3 experiments and was weakly detected in IgG–ASC in 1/3 ex-
periments. The RT-PCR product of a housekeeping gene, GAPDH message is
illustrated as a loading control. 
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kine whose receptor is expressed by most leukocytes), but
also to TECK (CCL25). In control experiments, incuba-
tion with TECK had no effect on the numbers of IgA–
ASC detected or on the amount of IgA produced per ASC
during overnight cultures (data not shown), indicating that
the ASC arrived in the bottom chemoattractant wells by
migration. A representative ELISPOT well illustrating
IgA–ASC migration to TECK is presented as Fig. 1 B.
Consistent with their efficient response to TECK, sorted
IgA
 
 
 
 (but not IgG
 
 
 
) ASC express abundant messenger
RNA for the TECK receptor, CCR9 (Fig. 1 C; note the
presence of two bands, indicating expression of both
CCR9 splice variants).
Unlike most circulating naive and memory lymphocytes
including follicular (IgD
 
 
 
) B cells (5, 7) (illustrated in Fig.
1), neither IgA– nor IgG–ASC migrated to the lymphoid
tissue-expressed CCR7 ligands ELC/CCL19 (Fig. 1) or
SLC/CCL21 (data not shown), chemokines implicated in
homing to lymphoid organs. These results are consistent
with recent studies showing that ASC phenotype (B220
 
int
 
/
CD138
 
 
 
) splenocytes from alum/nitrophenyl chicken
 
 
 
-globulin-immunized mice migrate to SDF-1
 
 
 
 but not
ELC or SLC (14). Similarly, Wehrli et. al. has suggested
that early ASC phenotype cells can migrate to ELC and
SDF-1
 
 
 
, but that they largely lose these responses in associ-
ation with exit from their lymphoid sites of generation
(15). Thus most ASC may be programmed to migrate to
extralymphoid sites, rather than recirculate through sec-
ondary lymphoid tissues.
IgA–ASC are thought to be induced in the intestine-
associated Peyer’s patch and mesenteric lymph nodes. They
then travel via the lymphatic system through the thoracic
duct into the bloodstream. Many localize to or pass
through the spleen on their way to populating the intestinal
LP (16, 17). Some IgA-ASC also migrate to and reside in
the BM, where they contribute to systemic IgA production
(18). As shown in Fig. 2, TECK responsiveness is a com-
mon feature of IgA–ASC harvested from Peyer’s patches
and mesenteric lymph nodes, as well as spleen. On average,
BM IgA–ASC responded relatively less well to TECK (al-
though the difference observed is not statistically signifi-
cance) (Fig. 2). In fact, migration of BM IgA–ASC to
TECK and SDF was variable and in some experiments was
significantly less than migration by IgA–ASC from MLN or
spleen. These differences may reflect variability in the pro-
portion of terminally differentiated plasma cells in the BM
(see below), where mature plasma cells are expected to be
present at a higher frequency than in lymphoid organs.
The development of naive B cells into differentiated
IgA–ASC is associated with the gain of surface IgA expres-
sion and a progressive decrease in B220 levels; few if any
ASC express B220 at the high levels seen on naive or ger-
minal center B cells, and many terminally differentiated tis-
sue plasma cells are B220
 
neg
 
 (19). The gut LP is a major site
of IgA–ASC recruitment and the relative high percentage
of IgA–ASC in this organ allowed us to address the B220
levels of the TECK-responsive IgA–ASC. (The cytological
and histochemical terms “plasmablasts” and “plasma cells”
have been used inconsistently in reference to ASC express-
ing varying levels of B220 [references 14, 15, 19, and 20),
and will not be used here). Fig. 3 A illustrates that both
IgA
 
 
 
/B220intermediate (B220
 
int
 
) and IgA
 
 
 
/B220
 
neg
 
 large
lymphocytes are found in the LP, and we have confirmed
that both of these populations comprise IgA–ASC (unpub-
lished data). Fig. 3 B demonstrates that the IgA
 
 
 
/B220
 
int
 
LP IgA–ASC population responds much better to TECK
than IgA
 
 
 
/B220
 
neg
 
 ASC. The LP IgA
 
 
 
/B220
 
neg
 
 ASC pop-
ulation had also lost its responsiveness to SDF-1
 
 
 
 (similar
to a B220
 
neg
 
/CD138
 
hi
 
 lymph node population described by
Wehrli et. al., reference 15). Splenic TECK-responsive
IgA–ASC were also restricted to the IgA
 
 
 
/B220
 
int
 
 but not
IgA
 
 
 
/B220
 
neg
 
 ASC populations (data not shown). IgA
 
 
 
/
B220
 
neg
 
 ASC may represent cells that have terminally
homed to the site of their final residence with no further
need for migratory receptors.
We next asked whether cells producing antibody in re-
sponse to a well-defined intestinally restricted pathogen
could also migrate to TECK. RV, a double-stranded RNA
virus, exclusively infects the small intestine villous epithe-
lium in humans and mice, causing diarrhea (21). RV is re-
sponsible for up to a million childhood deaths per year.
Protection against RV in immunodeficient mice can be
conferred by transfer of immune B cells, and immunity
correlates with anti-RV IgA but not anti-RV IgG levels in
Figure 2. IgA–ASC in Peyer’s patch, mesenteric lymph nodes, and
spleen migrate well to TECK. Lymphocytes were harvested from the in-
dicated lymphoid organs and the migration of IgA–ASC present in these
organs to medium (Basal) or medium containing 300 nM mTECK or 50
nM hSDF-1   was assessed as described in Materials and Methods. The
data is the mean   SEM from 3 to 9 individual experiments. The fre-
quency of IgA–ASC in the Peyer’s patch, mesenteric lymph node, spleen,
and BM were 70   40, 90   50, 60   20, and 25   10 per 106 total cells
plated, respectively. The fold-increase in specific migration over basal mi-
gration to TECK and SDF by IgA–ASC from Peyer’s patch was 4.7 and
3.8, respectively; from mesenteric lymph node was 19.8 and 12.6, respec-
tively, and from spleen was 63.8 and 31.8, respectively. BM–IgA ASC
had zero (below detectable) basal migration precluding presentation of a
fold-increase over basal. 
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the mouse model (22, 23). Mesenteric lymph node cells
were harvested from mice 10 d after RV infection, and
cells migrating to TECK or SDF-1
 
 
 
 were tested for the
isotype of anti-RV antibody production by modified (anti-
gen-specific) ELISPOT assay (8, 9). RV-specific IgA-ASC
represent 
 
 
 
10–12% of total IgA ASC in mesenteric nodes
at this time (9). Fig. 4 shows that these RV-specific IgA–
ASC migrate strongly to TECK. In contrast, in an experi-
ment in which mesenteric node IgG–ASC were assessed in
parallel, RV-specific IgG-ASC did not respond to TECK
above background (data not shown). The frequency of
RV-specific IgA–ASC migration to TECK was compara-
ble to that of the total IgA–ASC population in the same
experiments. We conclude that IgA–ASC induced by small
intestinal infection with RV display efficient chemotaxis to
TECK.
Migration to the widely expressed chemokine SDF-1
 
  
 
is
a property shared with most mature leukocytes, and many
other cell types as well (24). Such a general response may
contribute to motility within tissues or retention within a
tissue (14), but is unlikely to control differential tissue and
subset-specific cell homing. In contrast, recent studies of
TECK tissue expression patterns reveal that it is critically
positioned to contribute to IgA–ASC localization in the
gut. TECK mRNA is highly expressed in the thymus,
where it is hypothesized to participate in T cell develop-
ment (25, 26). In the periphery however, TECK mRNA is
largely restricted to the gastrointestinal tract, especially the
small intestinal mucosa (27, 28). In situ hybridization and
immunohistochemistry reveal TECK expression by epithe-
lial cells in the jejunum, duodenum and ileum, especially
but not exclusively in the crypt regions near the base of in-
testinal villi (28, 29). This region is enriched in MAd-
CAM-1
 
 
 
 venules supporting extravasation of homing lym-
phocytes, as well. Additional chemoattractants, possibly
including SDF-1
 
 
 
 (30), may support further migration and
dispersal of ASC throughout the intestinal LP. In contrast,
TECK is poorly expressed by nonintestinal epithelial tissues
(28). Thus, the studies presented here lead to the hypothe-
sis that selective expression of TECK by intestinal epithelial
cells may serve to efficiently recruit IgA–ASC to the gas-
trointestinal LP, and it will be of interest to assess the role
of TECK in circulating ASC interactions with LP venules,
and in diapedesis into the LP, in future in situ studies. In-
terestingly, TECK is expressed at lower levels in the colon
than in the small intestines. It could contribute to ASC mi-
gration there as well, but other chemoattractants may play
parallel roles in the homing of IgA–ASC to the colon and
other mucosal tissues.
Our results provide the first demonstration that ASC re-
spond to chemokines and demonstrate further the special-
ization of chemokine responses can be associated, at the
population level, with ASC specialization in terms of iso-
type expression. The selective recruitment of IgA–ASC by
the intestinal chemokine TECK not only provides a mech-
anism for the recruitment and/or retention of mucosal
ASC in the intestinal wall as originally hypothesized by
Lamm (4), but may also provide a paradigm in which tis-
sue-selective chemokine expression by specialized epithelia
helps determine the character of local humoral and cellular
immune responses.
Figure 3. B220int but not
B220 IgA  ASC phenotype
cells in LP migrate to TECK.
LPLs were stained for B220,
IgA, and for excluded lineage
markers (a dump cocktail or
anti-Thy1.1, NK1.1, IgD, and
CD11c). (A) Large lymphocytes
were gated for dump negativity
and plotted for B220 versus IgA
expression. The indicated gates
were used to determine migra-
tion efficiency of the different
populations. (B) LPLs were al-
lowed to migrate to medium (white bars), 100 nM hSDF-1   (gray bars), or 250 nM mTECK (black bars). Responding cells were stained as above
and the migration by the indicated cell population to chemokine presented. Migration of a B220hi, IgAneg population (presumed blasting B cells) is
shown for comparison.
Figure 4. RV-specific IgA–ASC migrate to TECK. Mesenteric lymph
node cells from RV-infected mice were harvested, enriched for ASC,
and allowed to migrate to medium (Basal) or medium containing opti-
mal chemotactic concentrations of mTECK (300 nM) or SDF-1  (50
nM). RV-specific IgA–ASC were identified and enumerated as de-
scribed in Materials and Methods. The data is the mean   range from
two independent experiments. 
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